16-89517401-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 1P and 10B. PP3BP6_ModerateBA1

The NM_003119.4(SPG7):​c.376+4364C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 141,026 control chromosomes in the GnomAD database, including 14,151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.42 ( 14138 hom., cov: 30)
Exomes 𝑓: 0.49 ( 13 hom. )

Consequence

SPG7
NM_003119.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.969

Publications

14 publications found
Variant links:
Genes affected
SPG7 (HGNC:11237): (SPG7 matrix AAA peptidase subunit, paraplegin) This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014]
SPG7 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 7
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 16-89517401-C-T is Benign according to our data. Variant chr16-89517401-C-T is described in ClinVar as Benign. ClinVar VariationId is 1169989.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.656 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPG7NM_003119.4 linkc.376+4364C>T intron_variant Intron 3 of 16 ENST00000645818.2 NP_003110.1 Q9UQ90-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPG7ENST00000645818.2 linkc.376+4364C>T intron_variant Intron 3 of 16 NM_003119.4 ENSP00000495795.2 Q9UQ90-1

Frequencies

GnomAD3 genomes
AF:
0.423
AC:
59586
AN:
140830
Hom.:
14132
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.310
Gnomad AMI
AF:
0.452
Gnomad AMR
AF:
0.470
Gnomad ASJ
AF:
0.492
Gnomad EAS
AF:
0.675
Gnomad SAS
AF:
0.557
Gnomad FIN
AF:
0.445
Gnomad MID
AF:
0.612
Gnomad NFE
AF:
0.443
Gnomad OTH
AF:
0.497
GnomAD4 exome
AF:
0.489
AC:
45
AN:
92
Hom.:
13
Cov.:
0
AF XY:
0.488
AC XY:
40
AN XY:
82
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.500
AC:
1
AN:
2
South Asian (SAS)
AF:
0.571
AC:
8
AN:
14
European-Finnish (FIN)
AF:
0.500
AC:
2
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.456
AC:
31
AN:
68
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.423
AC:
59606
AN:
140934
Hom.:
14138
Cov.:
30
AF XY:
0.428
AC XY:
29423
AN XY:
68710
show subpopulations
African (AFR)
AF:
0.310
AC:
11986
AN:
38686
American (AMR)
AF:
0.470
AC:
6723
AN:
14304
Ashkenazi Jewish (ASJ)
AF:
0.492
AC:
1591
AN:
3232
East Asian (EAS)
AF:
0.675
AC:
3233
AN:
4790
South Asian (SAS)
AF:
0.557
AC:
2438
AN:
4376
European-Finnish (FIN)
AF:
0.445
AC:
4328
AN:
9720
Middle Eastern (MID)
AF:
0.613
AC:
173
AN:
282
European-Non Finnish (NFE)
AF:
0.443
AC:
27811
AN:
62808
Other (OTH)
AF:
0.497
AC:
945
AN:
1900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1624
3248
4871
6495
8119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.444
Hom.:
20635
Bravo
AF:
0.428
Asia WGS
AF:
0.555
AC:
1770
AN:
3196

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 7 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
22
DANN
Benign
0.48
PhyloP100
-0.97
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.67
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.67
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8052076; hg19: chr16-89583809; API